Francesco Costacurta

Author

Also Known As

Costacurta, Francesco, Francesco Costacurta

Publications

429

Citations

H-Index

Concepts

All Affiliations

Francesco Costacurta is an author at Universität Innsbruck specializing in virology, medicine, and covid-19.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	14
2	Immunology	1	1	14
3	Molecular Biology	1	1	14
4	Covid-19	1	1	14
5	Virology	1	1	14

Francesco Costacurta

Publications

405

Citations

H-Index

Page 1

	Year	Citations
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, Science Advances	2023	164
SARS-CoV-2 3CL <sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Science Translational Medicine	2022	131
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil,	2022	42
A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition Emmanuel Heilmann, Francesco Costacurta, Stephan Geley, Communications Biology	2022	31
SARS-CoV-2 3CLpro mutations confer resistance to Paxlovid (nirmatrelvir/ritonavir) in a VSV-based, non-gain-of-function system Emmanuel Heilmann, Francesco Costacurta, André Volland, Abstract Protease InhibitorsViral EvolutionMolecular VirologyNon-gain-of-function SystemMedicine	2022	14
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir Laura Krismer, Helge Schöppe, Stefanie Rauch, npj Viruses	2024	13
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system Francesco Costacurta, Andrea Dodaro, David Bante, PLoS Pathogens	2024	10

Page 1